145 related articles for article (PubMed ID: 21181414)
1. PTOV1 is overexpressed in human high-grade malignant tumors.
Fernández S; Mosquera JL; Alaña L; Sanchez-Pla A; Morote J; Ramón Y Cajal S; Reventós J; de Torres I; Paciucci R
Virchows Arch; 2011 Mar; 458(3):323-30. PubMed ID: 21181414
[TBL] [Abstract][Full Text] [Related]
2. Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
Rausch S; Hennenlotter J; Scharpf M; Teepe K; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
J Cancer Res Clin Oncol; 2016 May; 142(5):937-47. PubMed ID: 26746655
[TBL] [Abstract][Full Text] [Related]
3. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
[TBL] [Abstract][Full Text] [Related]
4. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
6. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
7. The role of prostate tumor overexpressed 1 in cancer progression.
Cánovas V; Lleonart M; Morote J; Paciucci R
Oncotarget; 2017 Feb; 8(7):12451-12471. PubMed ID: 28029646
[TBL] [Abstract][Full Text] [Related]
8. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle.
Santamaría A; Fernández PL; Farré X; Benedit P; Reventós J; Morote J; Paciucci R; Thomson TM
Am J Pathol; 2003 Mar; 162(3):897-905. PubMed ID: 12598323
[TBL] [Abstract][Full Text] [Related]
9. A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.
Maggio V; Cánovas V; Félix AJ; Gómez V; de Torres I; Semidey ME; Morote J; Noé V; Ciudad CJ; Paciucci R
Cancer Lett; 2019 Jun; 452():158-167. PubMed ID: 30922918
[TBL] [Abstract][Full Text] [Related]
10. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
11. PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.
Benedit P; Paciucci R; Thomson TM; Valeri M; Nadal M; Càceres C; de Torres I; Estivill X; Lozano JJ; Morote J; Reventós J
Oncogene; 2001 Mar; 20(12):1455-64. PubMed ID: 11313889
[TBL] [Abstract][Full Text] [Related]
12. [Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms].
Allina DO; Andreeva YY; Zavalishina LE; Moskvina LV; Frank GA
Arkh Patol; 2016; 78(5):9-14. PubMed ID: 27804940
[TBL] [Abstract][Full Text] [Related]
13. PTOV1 is associated with UCH-L1 and in response to estrogen stimuli during the mouse oocyte development.
Yao YW; Shi Y; Jia ZF; Jiang YH; Gu Z; Wang J; Aljofan M; Sun ZG
Histochem Cell Biol; 2011 Aug; 136(2):205-15. PubMed ID: 21678139
[TBL] [Abstract][Full Text] [Related]
14. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1.
Marqués N; Sesé M; Cánovas V; Valente F; Bermudo R; de Torres I; Fernández Y; Abasolo I; Fernández PL; Contreras H; Castellón E; Celià-Terrassa T; Méndez R; Ramón Y Cajal S; Thomson TM; Paciucci R
Oncogene; 2014 Feb; 33(9):1124-34. PubMed ID: 23455324
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase.
Scarpelli M; Mazzucchelli R; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2012; 25(1):67-74. PubMed ID: 22507319
[TBL] [Abstract][Full Text] [Related]
16. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers.
Liu F; Li Z; Wan S; Li Y; Ye Z; Li D
Curr Cancer Drug Targets; 2023 Mar; ():. PubMed ID: 36927431
[TBL] [Abstract][Full Text] [Related]
18. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
[TBL] [Abstract][Full Text] [Related]
19. High expression of prostate tumor overexpressed 1 (PTOV1) is a potential prognostic biomarker for cervical cancer.
Chen Y; Hu Z; Chai D
Int J Clin Exp Pathol; 2017; 10(11):11044-11050. PubMed ID: 31966450
[TBL] [Abstract][Full Text] [Related]
20. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
Cánovas V; Puñal Y; Maggio V; Redondo E; Marín M; Mellado B; Olivan M; Lleonart M; Planas J; Morote J; Paciucci R
Oncotarget; 2017 Aug; 8(35):59165-59180. PubMed ID: 28938627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]